Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Treasury Shares (2023 - 2025)

Apyx Medical's Treasury Shares history spans 3 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Treasury Shares changed 0.08% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $2.1 million, changed 0.08%, while the annual FY2025 figure was $2.1 million, 0.08% changed from the prior year.
  • Treasury Shares reached $2.1 million in Q4 2025 per APYX's latest filing, roughly flat from $2.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $2.1 million in Q4 2025 to a low of $2.1 million in Q4 2023.
  • Average Treasury Shares over 3 years is $2.1 million, with a median of $2.1 million recorded in 2024.
  • Peak YoY movement for Treasury Shares: increased 3.16% in 2024, then increased 0.08% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $2.1 million in 2023, then rose by 3.16% to $2.1 million in 2024, then grew by 0.08% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for APYX's Treasury Shares are $2.1 million (Q4 2025), $2.1 million (Q4 2024), and $2.1 million (Q4 2023).